IOP announces 2009 award winners

03-Jul-2009 - United Kingdom

Successful business applications such as drug screening technologies, flat-panel displays and solar-cell designs are amongst the achievements in physics recognised by the Institute of Physics' (IOP) 2009 awards along with leading research in a wide range of fields from astronomy to optical physics, and excellence in engaging the general public with physics.

Dr Rachel McKendry, chosen for the successful commercial development of sensors for rapid disease diagnostics and antibiotic drug screening applications; Professor Sir Richard Friend and Dr David Fyfe, for establishing and managing their UK company Cambridge Display Technology (CDT) to become the world leader in light-emitting polymer technology; and Professor Donal D C Bradley, who demonstrated the widespread application potential of polymers - are just some of this year's winners who highlight physics' important contribution to the UK economy.

Dr Robert Kirby Harris, chief executive of the IOP, said "The IOP awards are a wonderful way of honouring the achievements of physicists across a range of fields as well as underlining the important role physics has in adding considerable value to the UK – both directly and also in underpinning engineering and other sciences".

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures